Molecular targeted therapies for breast cancer treatment

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Targeting oestrogen receptor, HER2 (human epidermal growth factor receptor 2), and vascular endothelial growth factor has significantly advanced breast cancer treatment.
• Understanding molecular pathways is crucial for developing effective cancer therapies.

Purpose of the Study:

• To describe new targeted therapeutic strategies for breast cancer.
• To discuss molecular pathways involved in cancer progression and potential therapeutic interventions.
• To review preclinical and clinical findings on novel anti-cancer mechanisms.

Main Methods:

• Review of current literature on targeted breast cancer therapies.
• Analysis of molecular pathways including apoptosis, cell cycle, and angiogenesis.
• Discussion of preclinical and clinical data for novel therapeutic approaches.

Main Results:

• Established targeted therapies (oestrogen receptor, HER2, VEGF) have shown marked improvements in breast cancer treatment.
• Emerging targeted approaches focus on inducing apoptosis, inhibiting anti-apoptosis, and controlling cell cycle progression.
• Inhibition of signal transduction and angiogenesis represents a promising area for new therapeutic development.

Conclusions:

• Targeted therapies have revolutionized breast cancer treatment by focusing on specific molecular pathways.
• Further research into novel targeted approaches, including those affecting apoptosis, cell cycle, and angiogenesis, holds significant promise.
• Integrating preclinical and clinical findings is essential for advancing targeted breast cancer therapy.